|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2011-7-21
|
|
pubmed:abstractText |
The imminent publication of a randomised controlled trial from the USA that suggests CT screening reduces mortality from lung cancer by more than 20%, may potentially lead to one of the most important developments in lung cancer care. However, there remain important questions about the applicability of the results to the UK and the clinical effectiveness of this intervention, including its feasibility and cost-effectiveness.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1468-3296
|
|
pubmed:author |
pubmed-author:BaldwinDavidD,
pubmed-author:BrainKateK,
pubmed-author:DevarajAnandA,
pubmed-author:DuffyStephen WSW,
pubmed-author:EisenTimT,
pubmed-author:FieldJohn KirkpatrickJK,
pubmed-author:HansellDavid MDM,
pubmed-author:KerrKeithK,
pubmed-author:PageRichardR,
pubmed-author:ParmarMaheshM,
pubmed-author:UKLS Team,
pubmed-author:WellerDavidD,
pubmed-author:WhynesDavidD,
pubmed-author:WilliamsonPaulaP
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
66
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
736-7
|
|
pubmed:meshHeading |
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
CT screening for lung cancer in the UK: position statement by UKLS investigators following the NLST report.
|
|
pubmed:affiliation |
Department of Molecular & Clinical Cancer Medicine, University of Liverpool, 200 London Road, Liverpool L3 9TA, UK. j.k.field@liv.ac.uk
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
